Pfizer’s new rare-disease meds Vyndaqel, Vyndamax reach blockbuster threshold despite pandemic hurdles esagonowsky Tue, 02/02/2021 – 10:53 More: Pfizer's new rare-disease meds Vyndaqel, Vyndamax reach blockbuster threshold despite pandemic hurdles Source: fierce
read moreVertex CEO faces growing pressure for pipeline deals despite major hike in Trikafta sales arlene.weintraub Tue, 02/02/2021 – 10:36 More: Vertex CEO faces growing pressure for pipeline deals despite major hike in Trikafta sales Source: fierce
read moreCDMO Catalent trumpets biologics windfall courtesy of COVID-19 fkansteiner Tue, 02/02/2021 – 10:17 More: CDMO Catalent trumpets biologics windfall courtesy of COVID-19 Source: fierce
read moreCHMP recommended marketing authorisation for human growth hormone therapy More: Novo Nordisk’s Sogroya moves closer towards EU approval Source: News
read moreEuropean Commission has authorised treatment for uncontrolled asthma patients More: EU approves Chiesi’s triple combination asthma therapy Trimbow Source: News
read moreUK government has signed a deal for a further 40 million doses of vaccine More: UK bolsters Valneva COVID-19 vaccine deal Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals